Nucleus Research

Nucleus Network is a leading multi-site Phase 1 clinical research organization (CRO) with a global presence, operating major facilities in Australia and the United States. The company specializes in early-phase clinical trials, including first-in-human studies, bioequivalence, and complex Phase 1/2 trials across a wide range of therapeutic areas. By leveraging Australia's favorable regulatory environment and the strategic location of its Minneapolis site, Nucleus Network provides pharmaceutical and biotechnology sponsors with rapid recruitment capabilities and high-quality clinical data. Their service suite encompasses clinical conduct, recruitment, and data management, making them a critical partner for developers transitioning candidates from preclinical stages to clinical proof-of-concept.